Many investors appear to be quite bearish on Dendreon Corporation (DNDN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.92% of the float is ...

Investors in Dendreon Corp (NASD: DNDN) saw new options become available today, for the February 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

In trading on Thursday, shares of Dendreon Corp (NASD: DNDN) crossed below their 200 day moving average of $5.48, changing hands as low as $5.46 per share. Dendreon Corp shares are currently trading ...

Investors are always looking for stocks that are poised to beat at earnings season and Dendreon Corp. (DNDN) may be one such company. The firm has earnings coming up pretty soon, and events are ...

As we’ve learned over the past few years, getting a drug approved by the Food and Drug Administration is just half the battle in the biotech sector. Too many biotech companies have relied on the past ...

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis. Now what: Dendreon ...

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. The news ...